Clinical Trial Update: Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of brodalumab versus placebo in Axial Spondyloarthritis has been withdrawn. The trial will not proceed under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Amgen | Conditions: Axial Spondyloarthritis | Phase 2 | Status: WITHDRAWN